Metabolic predictors of pain, fatigue, depression and quality of life in people with long‐term type 1 diabetes—the Dialong study

To examine associations of metabolic parameters (mean 30 years' time‐weighted HbA1c and low‐density lipoprotein‐cholesterol [LDL‐c], current methionine sulfoxide [MetSO], advanced glycation end products [AGEs], inflammatory markers and hypoglycaemia) with pain, fatigue, depression and quality of life (QoL) in people with long‐term type 1 diabetes.

[1]  G. Tell,et al.  Higher levels of bodily pain in people with long‐term type 1 diabetes: associations with quality of life, depressive symptoms, fatigue and glycaemic control – the Dialong study , 2020, Diabetic medicine : a journal of the British Diabetic Association.

[2]  V. Monnier,et al.  Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study , 2020, PloS one.

[3]  B. Namer,et al.  Methylglyoxal causes pain and hyperalgesia in human through C-fiber activation. , 2019, Pain.

[4]  T. J. Berg,et al.  Undiagnosed coronary artery disease in long-term type 1 diabetes. The Dialong study. , 2019, Journal of diabetes and its complications.

[5]  I. Thyberg,et al.  Upper extremity impairments in type 1 diabetes with long duration; common problems with great impact on daily life , 2019, Disability and rehabilitation.

[6]  M. Roden,et al.  Longitudinal associations between biomarkers of inflammation and changes in depressive symptoms in patients with type 1 and type 2 diabetes , 2018, Psychoneuroendocrinology.

[7]  A. Karter,et al.  The Bidirectional Association Between Depression and Severe Hypoglycemic and Hyperglycemic Events in Type 1 Diabetes , 2017, Diabetes Care.

[8]  K. Hunt,et al.  Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes , 2017, Diabetes Care.

[9]  V. Monnier,et al.  Hand, shoulder and back stiffness in long-term type 1 diabetes; cross-sectional association with skin collagen advanced glycation end-products. The Dialong study. , 2017, Journal of diabetes and its complications.

[10]  J. Brox,et al.  Very High Prevalence of Frozen Shoulder in Patients With Type 1 Diabetes of ≥45 Years' Duration: The Dialong Shoulder Study. , 2017, Archives of physical medicine and rehabilitation.

[11]  J. Brox,et al.  Long term type 1 diabetes is associated with hand pain, disability and stiffness but not with structural hand osteoarthritis features – The Dialong hand study , 2017, PloS one.

[12]  P. Dagnelie,et al.  Advanced Glycation End Product (AGE) Accumulation in the Skin is Associated with Depression: The Maastricht Study , 2017, Depression and anxiety.

[13]  H. Knoop,et al.  Severe fatigue in type 1 diabetes: Exploring its course, predictors and relationship with HbA1c in a prospective study. , 2016, Diabetes research and clinical practice.

[14]  S. Genuth,et al.  The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes , 2016, Glycoconjugate Journal.

[15]  C. Cowie,et al.  Risk Factors for Cardiovascular Disease in Type 1 Diabetes , 2016, Diabetes.

[16]  K. Hunt,et al.  Longitudinal Association Between Endothelial Dysfunction, Inflammation, and Clotting Biomarkers With Subclinical Atherosclerosis in Type 1 Diabetes: An Evaluation of the DCCT/EDIC Cohort , 2015, Diabetes Care.

[17]  D. Nathan,et al.  Musculoskeletal Complications in Type 1 Diabetes , 2014, Diabetes Care.

[18]  Hans Knoop,et al.  Chronic Fatigue in Type 1 Diabetes: Highly Prevalent but Not Explained by Hyperglycemia or Glucose Variability , 2013, Diabetes Care.

[19]  D. Nathan,et al.  The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview , 2013, Diabetes Care.

[20]  Paul J Thornalley,et al.  Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy , 2012, Nature Medicine.

[21]  Jennifer K. Sun,et al.  Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration , 2011, Diabetes Care.

[22]  S. Wessely,et al.  Development of a fatigue scale. , 1993, Journal of psychosomatic research.

[23]  C. Jackson,et al.  The Chalder Fatigue Scale (CFQ 11). , 2015, Occupational medicine.

[24]  P. Cleary,et al.  The Long-Term Effects of Type 1 Diabetes Treatment andComplications on Health-Related Quality of Life A 23-year follow-up of the Diabetes Control and Complications / Epidemiology of Diabetes Interventions and Complications cohort , 2013 .

[25]  Morten Wang Fagerland,et al.  Associations with glycemic control and advanced protein glycation: The Oslo Study , 2013 .

[26]  C. Todd,et al.  The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL , 2004, Quality of Life Research.

[27]  J. Ware.  SF-36 health survey: Manual and interpretation guide , 2003 .

[28]  R. Spitzer,et al.  The PHQ-9: validity of a brief depression severity measure. , 2001, Journal of general internal medicine.